YL5084
YL5084, a covalent JNK inhibitor, exhibits selectivity for JNK2 and JNK3 over JNK1 with IC50s of 70 nM, 84 nM and 2173 nM, respectively. YL5084 exhibits JNK2-independent antiproliferative effects and induces apoptosis in a JNK2-independent manner.
For research use only. We do not sell to patients.
- CAS No.: 2440199-73-3
- Formula: C35H36N8O2
- Molecular Weight:600.71
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
JNK2 70 nM (IC50) |
JNK3 84 nM (IC50) |
JNK1 2173 nM (IC50) |
YL5084 (0.001-100 μM; 72 h) displays dose-dependent antiproliferative effects with GR50 values of 200-300 nM in MM.1S cells[1].
YL5084 (0.5, 2.5 μM; 24 h) induces apoptosis[1].
YL5084 displays weaker inhibition against PIKFYVE (KD=5000 nM in a KdELECT binding assay) in KINOMEscan[1].
YL5084 has moderate metabolic stability in human and mice microsomes with half-lives of 16 and 11 min, respectively [1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Multiple myeloma (MM) cell lines
-
Concentration:0.001-100 μM
-
Incubation Time:72 h
-
Result:Displayed dose-dependent antiproliferative effects with GR50 values of 200-300 nM.
-
Cell Line:MM.1S cells
-
Concentration:0.5, 2.5 μM
-
Incubation Time:24 h
-
Result:Induced apoptosis as evidenced by an increased level of PARP cleavage, an increased level of cleavage of caspase 3, and an increased level of Annexin V/PI staining.
Chemical Information
-
CAS No. 2440199-73-3
-
Molecular Weight 600.71
-
Formula C35H36N8O2
-
SMILES
O=C(C1=CC=C(C=C1)NC(/C=C/CN(C)C)=O)N(C[C@@H]2C)C[C@H]2NC3=NC=CC(C4=C(C=CC=C5)N5N=C4C6=CC=CC=C6)=N3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)